Call us on+91-7807096339
Get a Quote

Welcome to Biozenta

Biozenta is the vertically integrated, one of the leading and fastest growing pharmaceutical and life sciences group of companies with its presence in various therapies like Oncology, Anti-cancer, Cytotoxic, Critical-care, Life-saving, General Injectables, Contrast Media Injectables, Oral Solids - Tablets and Capsules – including Ant-retrovirals (ARVs), External Preparations – Derma and Cosmetics and also vertically integrated for key Oncology Active Pharmaceutical Ingredients (API’s).

Biozenta, a very versatile, fast growing and dynamic organization, established in the year 2018 with a major emphasis to serve the humanity through quality medicines to live the vision “Human helping Human”

Firm believer in Research and Innovation, Biozenta has focused on very unique and innovative products in across the healthcare range. With the state-of-the-art multi-locational EU-GMP approvable facilities, WHO GMP and PICs approved, located in one of the strategic Pharmaceutical Industrial zone of UNA District of H.P., having ultra-modern and well-equipped infrastructure for various units as below:

  • Oncology Facility - dedicated, completely isolated & separate unit at UNA, H.P., covers all the major dosage forms in Oncology, Anti-cancer, Cytotoxic range - Liquid Injectables, Lyophilized Injectables, Pre-filled Syringes (PFS) & Oral Solids - Tablets and Capsules.
  • General Facility – st&-alone & separate unit at UNA, H.P., covering all major dosage forms of Liquid Injectables, Lyophilized Injectables, Pre-filled Syringes (PFS), Contrast Media Injectables & Oral Solids - Tablets and Capsules, including Antiretrovirals (ARVs) products.
  • External preparations - separate unit formed as “Biogracea Medicare” at UNA H.P., covering all Topical forms of Derma & Cosmetics such as Cream, Ointment, Gel, Lotion, Shampoo & Dusting powder, etc.
  • Active Pharmaceutical Ingredients Unit - dedicated Oncology, Anti-cancer, Cytotoxic API and Intermediates facility located at UNA, H.P. to make company self-sufficient & vertically integrated with focus on to improve the synthetic procedures, Quality & stability of the Raw materials.

Milestones:

2018

First
Milestone

Biozenta registered its company in Roorkee, Uttarakhand.

2019

Second
Milestone

Started its Oncology and Critical Care manufacturing Unit at UNA, H.P.

2021

Third
Milestone

Started manufacturing unit for General range Plant for Injectables, Lyophilized Injectables, PFS, Contrast Media and Oral Solids at UNA H.P.

2021

Fourth
Milestone

Established, "Biogracea Medicare", a c-GMP compliant manufacturing unit for “External Preparation Drugs and Cosmetics” at UNA, H. P.

2021

Fifth
Milestone

Started its unique RandD Lab with advanced technology for “MAB-development” (Monoclonal antibody) in Chandigarh.

2021

Sixth
Milestone

Started its corporate office at Mohali Punjab for Business Development Activities and Regulatory Support.

2023

Seventh
Milestone

Proudly received “PICs” approval for Oncology and General Range manufacturing Unit based at UNA, H.P.

2023

Eighth
Milestone

Inaugurated its new “Corporate office” as “Biozenta House” in Mumbai.

2023

Ninth
Milestone

Signed “Partnership deed with US partner for Biosimilar products” to be launched by 2024.

2023

Tenth
Milestone

"Launching into the Domestic Marketing Division" at Mohali, 2023.

2023

Eleventh
Milestone

Inaugurated its new “Corporate office” as “Biozenta, USA”

Leader in Innovation and Research.

Global flagship in manufacturing of critical segments of Oncological injectable preparations like Nano particle drugs, Liposomal preparations, Lyophilised and Prefilled Syringe PFS.

Download Products Brochure

Management and Leadership

Mr. Deep Narayan Sharma, Founder and Managing Director of Biozenta group of companies is a sound technocrat and young, ambitious and dynamic leader. Completed his masters in pharmacy with MBA in Production Management having vast and sound experience in the field of Pharmaceutical manufacturing industry, is a first-generation entrepreneur of his family with lot of passion, focused approach and deep understanding of Oncology, Anti-cancer, Cytotoxic, Critical Care and Life Saving products with major focus on nano-particles and Liposomal technologies.

With 22+ years of experience in corporate industry at various levels including top management and his passion for Oncology, Anti-cancer, Cytotoxic, Critical Care and Life Saving products, he started his first venture in the year 2011 as Dr. Aarbidee Laboratories and Aarya Healthcare (A Division for Food Products) which has been later merged with Biozenta group in 2018.

Under the guiding principles and leadership of Mr. Deep Narayan Sharma, Biozenta achieved various new milestones and offered many innovative Oncology, Anti-cancer, Cytotoxic, Critical Care and Life Saving products.

Firm believer in hard work, self-belief, “walk the talk”, leading by examples, ambitious, innovative approach, “passion for work” are some of the key success factors which he wants to imbibe by every employee of the organization to achieve company’s vision of “Human Helping Human”

GLOBAL PRESENCE

Biozenta, a Indian Global Multinational Company:

Biozenta pursuing and exporting to over 30+ countries across the continents globally which include Asia, Africa, LATAM, CIS, MENA and Europe. With over 180+ international product registrations (many more are under registrations), Biozenta is emerging as one of the leading and fast growing major Indian pharmaceutical manufacturer and exporter. Biozenta is aggressively participating in all the Govt, MOH and local tenders of pharmaceutical formulations, across the globe.

Biozenta strives to be a world class pharmaceutical manufacturer for the development and providing high quality products with superior performance at affordable price. Biozenta’s formulation development and regulatory teams are focused on developing the latest generics to the global markets, with a commitment for continuous flow of innovative products across the globe, in all the therapeutic categories - Oncology, Anti-cancer, Cytotoxic, Critical-care, Life-saving, General Injectables, Contrast Media Injectables, Oral Solids - Tablets and Capsules – including Ant-retrovirals (ARVs), External Preparations – Derma and Cosmetics and also vertically integrated for key Oncology Active Pharmaceutical Ingredients (API’s).

Our Branded and Generic medicines enjoy steady demand in following countries:

  • Asia
    Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Philippines, Turkey, Turkmenistan, Uzbekistan, Vietnam, Indonesia, Malaysia, Tajikistan, etc.
  • Africa
    Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya,Congo, Gambia, Ivory Coast , etc.
  • North & South America
    Canada, Panama, Costa Rica, Dominican Republic, Guatemala, Guyana, Peru, Bolivia, Brazil, Bahamas, Ecuador, etc.
  • Europe
    Austria, Azerbaijan, Belarus, Georgia, Germany, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK), Latvia, etc.
  • OCEANIA
    Australia, New Zealand, Fiji, etc.
Biozenta Group of Companies
Request A Call Back
Register Drug Shortage
Online Enquiry
Job Opportunities